Log in

NYSE:NUS - Nu Skin Enterprises Stock Price, Forecast & News

$38.29
+0.59 (+1.56 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$37.94
Now: $38.29
$38.50
50-Day Range
$37.70
MA: $41.20
$46.56
52-Week Range
$35.03
Now: $38.29
$69.79
Volume304,350 shs
Average Volume607,898 shs
Market Capitalization$2.13 billion
P/E Ratio10.88
Dividend Yield3.93%
Beta0.75
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products. Read More…

Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
CUSIP67018T10
Phone801-345-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.68 billion
Cash Flow$5.09 per share
Book Value$14.11 per share

Profitability

Net Income$121.88 million

Miscellaneous

Employees4,900
Market Cap$2.13 billion
Next Earnings Date2/12/2020 (Estimated)
OptionableOptionable

Receive NUS News and Ratings via Email

Sign-up to receive the latest news and ratings for NUS and its competitors with MarketBeat's FREE daily newsletter.


Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Tuesday, November 5th. Shareholders of record on Friday, November 29th will be given a dividend of $0.37 per share on Wednesday, December 11th. This represents a $1.48 annualized dividend and a yield of 3.87%. The ex-dividend date is Wednesday, November 27th. View Nu Skin Enterprises' Dividend History.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its earnings results on Tuesday, November, 5th. The company reported $0.79 earnings per share for the quarter, topping analysts' consensus estimates of $0.76 by $0.03. The business had revenue of $590 million for the quarter, compared to analyst estimates of $605.02 million. Nu Skin Enterprises had a net margin of 4.59% and a return on equity of 23.52%. The company's revenue for the quarter was down 13.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.94 earnings per share. View Nu Skin Enterprises' Earnings History.

When is Nu Skin Enterprises' next earnings date?

Nu Skin Enterprises is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Nu Skin Enterprises.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises updated its fourth quarter earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $0.68-0.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.91. The company issued revenue guidance of $570-590 million, compared to the consensus revenue estimate of $642.26 million.

What price target have analysts set for NUS?

7 analysts have issued 1 year price targets for Nu Skin Enterprises' shares. Their forecasts range from $40.00 to $70.00. On average, they anticipate Nu Skin Enterprises' stock price to reach $50.29 in the next year. This suggests a possible upside of 31.3% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.

What is the consensus analysts' recommendation for Nu Skin Enterprises?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nu Skin Enterprises.

What are Wall Street analysts saying about Nu Skin Enterprises stock?

Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
  • 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past six months. Headwinds in Mainland China, a soft view for 2020 and currency fluctuations are prime deterrents. The recently completed 100-day government campaign in Mainland China to inspect offerings of the nutrition and direct sales industry led to adversities like limited sales meetings. This took a toll on the company’s third-quarter 2019 results, with revenues and earnings declining year over year. The company also issued a soft view for the fourth quarter and 2020, wherein adverse impacts from currency movements are likely to persist. Nevertheless, the company is on track with product launches and programs to strengthen sales leaders in Mainland China. Also, the company is committed toward boosting customer base, which grew 4% in the third quarter." (11/11/2019)
  • 2. Pivotal Research analysts commented, "We suspect that NUS management has taken an axe to the outlook to avoid having to cut again." (8/7/2019)

Has Nu Skin Enterprises been receiving favorable news coverage?

Media headlines about NUS stock have been trending extremely negative this week, according to InfoTrie. InfoTrie rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of -4.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near future. View News Stories for Nu Skin Enterprises.

Are investors shorting Nu Skin Enterprises?

Nu Skin Enterprises saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 1,490,000 shares, an increase of 24.2% from the September 15th total of 1,200,000 shares. Based on an average daily trading volume, of 490,600 shares, the short-interest ratio is presently 3.0 days. Approximately 2.8% of the company's shares are short sold. View Nu Skin Enterprises' Current Options Chain.

Who are some of Nu Skin Enterprises' key competitors?

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), Herbalife Nutrition (HLF), Marathon Petroleum (MPC), Home Depot (HD), Baidu (BIDU), Mastercard (MA), Alphabet (GOOG), Netflix (NFLX) and NVIDIA (NVDA).

Who are Nu Skin Enterprises' key executives?

Nu Skin Enterprises' management team includes the folowing people:
  • Mr. Steven J. Lund, Exec. Chairman (Age 66)
  • Mr. Ritch N. Wood, CEO & Director (Age 53)
  • Mr. Ryan S. Napierski, Pres (Age 45)
  • Mr. Mark H. Lawrence, Exec. VP & CFO (Age 49)
  • Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 66)

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (2.46%), Phoenix Holdings Ltd. (1.21%), Millennium Management LLC (0.63%), Assenagon Asset Management S.A. (0.57%), First Trust Advisors LP (0.42%) and Voya Investment Management LLC (0.36%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Edwina D Woodbury, Foulis Greg, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.

Which institutional investors are selling Nu Skin Enterprises stock?

NUS stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Squarepoint Ops LLC, Russell Investments Group Ltd., State Street Corp, SG Americas Securities LLC, Robeco Institutional Asset Management B.V., Voya Investment Management LLC and First Quadrant L P CA. View Insider Buying and Selling for Nu Skin Enterprises.

Which institutional investors are buying Nu Skin Enterprises stock?

NUS stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd., Assenagon Asset Management S.A., Mackay Shields LLC, State of New Jersey Common Pension Fund D, 1492 Capital Management LLC, Voloridge Investment Management LLC, Empirical Finance LLC and California Public Employees Retirement System. View Insider Buying and Selling for Nu Skin Enterprises.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $38.29.

How big of a company is Nu Skin Enterprises?

Nu Skin Enterprises has a market capitalization of $2.13 billion and generates $2.68 billion in revenue each year. The company earns $121.88 million in net income (profit) each year or $3.52 on an earnings per share basis. Nu Skin Enterprises employs 4,900 workers across the globe.View Additional Information About Nu Skin Enterprises.

What is Nu Skin Enterprises' official website?

The official website for Nu Skin Enterprises is http://www.nuskinenterprises.com/.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]


MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  470 (Vote Outperform)
Underperform Votes:  441 (Vote Underperform)
Total Votes:  911
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/7/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel